Becton Dickinson and Company (BDX)
NYSE · Healthcare · Medical Instruments & Supplies
Becton Dickinson and Company is a Healthcare company with a market capitalization of $42.96B, a trailing P/E ratio of 27.3, and a dividend yield of 2.76%.
5-Year Price History
Latest Annual Financials · FY ending September 30, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | May 7, 2026 | $2.90 | $2.77 | +4.7% |
| Q1 2025 | February 9, 2026 | $2.91 | $2.80 | +3.9% |
| Q4 2025 | November 6, 2025 | $3.96 | $3.91 | +1.3% |
| Q3 2025 | August 7, 2025 | $3.68 | $3.40 | +8.2% |
| Q2 2025 | May 1, 2025 | $3.35 | $3.28 | +2.1% |
| Q1 2024 | February 5, 2025 | $3.43 | $2.99 | +14.7% |
Other Medical Instruments & Supplies Stocks
Frequently Asked Questions
What is Becton Dickinson and Company's market cap?
As of June 29, 2026, Becton Dickinson and Company (BDX) has a market capitalization of $42.96B.
What is Becton Dickinson and Company's P/E ratio?
Becton Dickinson and Company trades at a trailing price-to-earnings (P/E) ratio of 27.3. Its forward P/E is 11.2.
Does Becton Dickinson and Company pay a dividend?
Yes — Becton Dickinson and Company pays a dividend yielding 2.76%, an annual payout of $4.18 per share.
What sector is BDX in?
Becton Dickinson and Company is in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
What was Becton Dickinson and Company's revenue?
In its latest reported fiscal year (ending September 30, 2025), Becton Dickinson and Company reported revenue of $21.84B and net income of $1.68B.
Ask your own questions about BDX
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.